The evidence tier that is fully published and verifiable is Phase 2
Clinical evidence suggests modest additive benefitstypically 5-7% additional weight lossthough individual outcomes vary
Operational Workflow for Med Spas Adding Peptides Offering peptides needs more than a supplier
Indeed, increased insulin secretion has been noticed in thyrotoxicosis in some early studies, which was usually considered as a compensatory response to lower the elevated blood glucose levels 37,38
The FDA approved liraglutide (Victoza) at doses of 0.6 mg, 1.2 mg, and 1.8 mg daily for T2DM patients with unsatisfactory diet or exercise control, and 2.4 mg and 3 mg as a chronic weight management drug
Some studies suggest that GLP-1 agonists may reduce the risk of cardiovascular events, like heart attacks and strokes, which is especially beneficial for people with diabetes or metabolic syndrome